Quarter
Charts
πŸ‡ΊπŸ‡ΈUS Markets

Silgan Holdings Inc.

SLGN

CIK 0000849869 Β· Quarterly mode Β· latest period FY2025 (Q4) (ending 2025-12-31) Β· sourced from SEC EDGAR

At a glance Β· FY2025 (Q4)

Revenue
$1.47B
↑+4.1% +$57Mvs FY2024 (Q4)
Operating Income
$52M
↑+37.5% +$14Mvs FY2024 (Q4)
Gross Profit
$253M
↑+5.7% +$14Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot Β· latest annual filed values Β· S&P 500 calibration

Poor
24/100
  • Profitability
    21ROIC 9.2% (10% = solid, 20%+ = moat)
  • Liquidity
    36Current Ratio 1.22 (above 1.5 = solid)
  • Leverage
    18D/E 1.63 (under 0.5 = conservative)
  • Efficiency
    37Asset Turnover 0.69x (1.0+ = capital-efficient)
  • Growth
    30Revenue YoY +4.1% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project SLGN's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -7.4%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≀ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$55.27
Total enterprise IV
$5.90B
Diluted shares
0.11B
Terminal PV
$4.16B (70% of total)
Year-5 FCF
$490M
YearProjected FCFDiscounted PV
+1$435M$396M
+2$448M$371M
+3$462M$347M
+4$476M$325M
+5$490M$304M
Terminal$6.70B$4.16B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target β€” and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation Β· trailing 4 quarters

how the company spent its cash
Capex (TTM)
$307M
investment in PP&E
Dividends paid (TTM)
$86M
cash returned to holders
Stock buybacks (TTM)
$75M
share count reduction

Balance sheet Β· 2025-12-31

latest filed snapshot
Total assets
$9.40B
everything owned
Stockholders' equity
$2.27B
shareholder claim
Net debt
$2.63B
LT debt minus cash

Recent performance Β· 67 quarters

Revenue↑+4.1% +$57M
$1.47B
Net Income↓-59.6% -$27M
$18M
Free Cash Flow↑+41.3% +$357M
$1.22B
Operating Margin↓-4.7pts
8.5%

Drill down